
Likarda
Kansas City, MO, United States likarda.com From their website, Nov 2026
Work here? Claim this listing
About
Likarda develops hydrogel encapsulation and drug delivery platforms for biotech, pharma, and research organizations. It works on cell therapies, biologics, peptides, proteins, antibodies, and small molecules, with applications in controlled release, protection, and delivery of therapeutics. The company is based in Kansas City.
Services
Core-Shell Spherification® (CSS®)
Encapsulates cells or therapeutics in customizable hydrogel microbeads for protection, localization, and controlled or sustained delivery.
CSS® Feasibility Study
Tests whether a molecule or cell therapy is compatible with the CSS® platform through a customized feasibility program.
CSS® Encapsulation for Preclinical and Animal Studies
Supports in vitro and in vivo preclinical studies using encapsulated formulations for PK/PD, biodistribution, dosing, and immune shielding.
VitaCell™
Provides biodegradable hydrogel microbeads for controlled delivery of therapeutic cells.
ViscoCell™
Provides an injectable stem cell hydrogel for joint and soft tissue repair.
EnduraCell™
Provides long-term immune protection for encapsulated therapeutic cells.
LiberaCell™
Supports cryopreservation and logistics for cell-based materials.
AegisCell™
Supports cryopreservation for cells.
6 more services
- AegisBio™
- NovoSphere™
- Provia™ Encapsulation Technologies
- Predictive Polymer Analytics™ (PPA™)
- CSS® Encapsulation Equipment
- Hydrogel & Cell Therapy Consultation
- Turnaround
- 6–8 weeks
- What to send
- Product for a CSS® feasibility study
- Molecule or cell therapy for encapsulation testing
- Hydrogel or cell therapy consultation inputs
Capabilities
- Assays and studies
- Cell therapy
- Small molecules
- Antibodies
- Peptides
- In vivo
- PK/PD
13 more
- Immunogenicity
- Rodent models
- In vitro screening
- In vivo studies
- Biodistribution
- Mechanism of action
- Immune shielding
- Viability testing
- Functionality testing
- Controlled release testing
- Formulation optimization
- Cryopreservation testing
- Immunogenicity models
- Scale and capacity
- 50+ biocompatible hydrogels
- 40+ cell types
- Therapeutic areas
- Diabetes
- Osteoarthritis
- Liver disease
- Oncology
- Musculoskeletal repair
- Localized inflammation
Instruments and platforms
- Core-Shell Spherification® (CSS®)
- Predictive Polymer Analytics™ (PPA™)
Modalities and species
- Modalities
- Small molecule
- Antibody
- Peptide
- Cell therapy
- Species and models
- Rodent
- Large animal
- Allogeneic cells
- Xenogeneic cells
- Single cell suspensions
- Adherent cells
- Spheroids
- Organoids
Certifications
As the company states them, with the certificate or registry record where there is one.
GMPSelf-reported
Details
- Quality
- FDA-accepted materials · dry ice transport · LN2 transport
- Office
- pioneering 3D cell culture platform to advance next-generation treatments